{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:57:59Z","timestamp":1791925079902,"version":"4.3.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The risk of developing late radiotoxicity after radiotherapy in patients with high chromosomal radiosensitivity after radiotherapy could potentially be higher compared to the risk in patients with average radiosensitivity. In case of extremely high radiosensitivity, dose reduction may be appropriate. Some rheumatic diseases (RhD), including connective tissue diseases (CTDs) appear to be associated with higher radiosensitivity. The question arises as to whether patients with rheumatoid arthritis (RA) also generally have a higher radiosensitivity and whether certain parameters could indicate clues to high radiosensitivity in RA patients which would then need to be further assessed before radiotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Radiosensitivity was determined in 136 oncological patients with RhD, 44 of whom were RA patients, and additionally in 34 non-oncological RA patients by three-colour fluorescence in situ hybridization (FiSH), in which lymphocyte chromosomes isolated from peripheral blood are analysed for their chromosomal aberrations of an unirradiated and an with 2\u00a0Gy irradiated blood sample. The chromosomal radiosensitivity was determined by the average number of breaks per metaphase.\u00a0In addition, correlations between certain RA- or RhD-relevant disease parameters or clinical features such as the disease activity score 28 and radiosensitivity were assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Some oncological patients with RhD, especially those with connective tissue diseases have significantly higher radiosensitivity compared with oncology patients without RhD. In contrast, the mean radiosensitivity of the oncological patients with RA and other RhD and the non-oncological RA did not differ. 14 of the 44 examined oncological RA-patients (31.8%) had a high radiosensitivity which is defined as \u2265\u20090.5 breaks per metaphase. No correlation of laboratory parameters with radiosensitivity could be established.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It would be recommended to perform radiosensitivity testing in patients with connective tissue diseases in general. We did not find a higher radiosensitivity in RA patients. In the group of RA patients with an oncological disease, a higher percentage of patients showed higher radiosensitivity, although the average radiosensitivity was not high.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-023-02291-8","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T13:03:24Z","timestamp":1686143004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chromosomal radiosensitivity in oncological and non-oncological patients with rheumatoid arthritis and connective tissue diseases"],"prefix":"10.1186","volume":"18","author":[{"given":"Dinah","family":"Rzepka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Geinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Silberberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Kaudewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Schonath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Ayala Gaona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Aschacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luitpold","family":"Distel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"2291_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s00066-017-1165-2","volume":"193","author":"T Hara","year":"2017","unstructured":"Hara T, Iwadate M, Tachibana K, Waguri S, Takenoshita S, Hamada N. Metastasis of breast cancer cells to the bone, lung, and lymph nodes promotes resistance to ionizing radiation. Strahlenther Onkol. 2017;193:848\u201355. https:\/\/doi.org\/10.1007\/s00066-017-1165-2","journal-title":"Strahlenther Onkol"},{"key":"2291_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00066-019-01559-x","volume":"196","author":"A Huang","year":"2020","unstructured":"Huang A, Xiao Y, Peng C, Liu T, Lin Z, Yang Q, Zhang T, Liu J, Ma H. 53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer. Strahlenther Onkol. 2020;196:465\u201373. https:\/\/doi.org\/10.1007\/s00066-019-01559-x","journal-title":"Strahlenther Onkol"},{"key":"2291_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.radonc.2006.10.012","volume":"81","author":"LV Distel","year":"2006","unstructured":"Distel LV, Neubauer S, Keller U, Sprung CN, Sauer R, Grabenbauer GG. Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients. Radiother Oncol. 2006;81:257\u201363. https:\/\/doi.org\/10.1016\/j.radonc.2006.10.012","journal-title":"Radiother Oncol"},{"key":"2291_CR4","doi-asserted-by":"publisher","first-page":"102881","DOI":"10.1016\/j.critrevonc.2020.102881","volume":"147","author":"L De Courcy","year":"2020","unstructured":"De Courcy L, Bezak E, Marcu LG. Gender-dependent radiotherapy: the next step in personalised medicine? Crit Rev Oncol Hematol. 2020;147:102881. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102881","journal-title":"Crit Rev Oncol Hematol"},{"key":"2291_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","volume":"25","author":"JK Sicklick","year":"2019","unstructured":"Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, De P, Krie A, Piccioni DE, Miller VA, et al. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat Med. 2019;25:744\u201350. https:\/\/doi.org\/10.1038\/s41591-019-0407-5","journal-title":"Nat Med"},{"key":"2291_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ijc.28940","volume":"137","author":"SE Jackson","year":"2015","unstructured":"Jackson SE, Chester JD. Personalised cancer medicine. Int J Cancer. 2015;137:262\u20136. https:\/\/doi.org\/10.1002\/ijc.28940","journal-title":"Int J Cancer"},{"key":"2291_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/17425255.2016.1196187","volume":"12","author":"NL Syn","year":"2016","unstructured":"Syn NL, Yong WP, Goh BC, Lee SC. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review. Expert Opin Drug Metab Toxicol. 2016;12:911\u201322. https:\/\/doi.org\/10.1080\/17425255.2016.1196187","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2291_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00066-021-01843-9","volume":"197","author":"D Krug","year":"2021","unstructured":"Krug D, Hecht M, Ebert N, M\u00e4urer M, Fleischmann DF, Fokas E, Straube C, Nicolay NH, H\u00f6rner-Rieber J, Schmitt D, et al. Innovative radiation oncology together \u2013 precise, personalized, human. Strahlenther Onkol. 2021;197:1043\u20138. https:\/\/doi.org\/10.1007\/s00066-021-01843-9","journal-title":"Strahlenther Onkol"},{"key":"2291_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1748-717X-6-32","volume":"6","author":"R Huber","year":"2011","unstructured":"Huber R, Braselmann H, Geinitz H, Jaehnert I, Baumgartner A, Thamm R, Figel M, Molls M, Zitzelsberger H. Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients - a follow-up study. Radiat Oncol. 2011;6:32. https:\/\/doi.org\/10.1186\/1748-717X-6-32","journal-title":"Radiat Oncol"},{"key":"2291_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00066-005-1372-0","volume":"181","author":"A Wistop","year":"2005","unstructured":"Wistop A, Keller U, Sprung CN, Grabenbauer GG, Sauer R, Distel LVR. Individual Radiosensitivity does not correlate with Radiation-Induced apoptosis in Lymphoblastoid Cell lines or CD3 + lymphocytes. Strahlenther Onkol. 2005;181:326\u201335. https:\/\/doi.org\/10.1007\/s00066-005-1372-0","journal-title":"Strahlenther Onkol"},{"key":"2291_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/02841860801885969","volume":"47","author":"DA Chistiakov","year":"2008","unstructured":"Chistiakov DA, Voronova NV, Chistiakov PA. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol. 2008;47:809\u201324. https:\/\/doi.org\/10.1080\/02841860801885969","journal-title":"Acta Oncol"},{"key":"2291_CR12","doi-asserted-by":"publisher","first-page":"503371","DOI":"10.1016\/j.mrgentox.2021.503371","volume":"867","author":"EE Ocolotobiche","year":"2021","unstructured":"Ocolotobiche EE, Dauder RM, G\u00fcerci AM. Radiosensitivity of radiotherapy patients: the effect of individual DNA repair capacity. Mutat Res Genet Toxicol Environ Mutagen. 2021;867:503371. https:\/\/doi.org\/10.1016\/j.mrgentox.2021.503371","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"2291_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.canrad.2020.06.007","volume":"24","author":"C Chargari","year":"2020","unstructured":"Chargari C, Supiot S, Hennequin C, Chapel A, Simon JM. [Treatment of radiation-induced late effects: what\u2019s new?]. Cancer Radiother. 2020;24:602\u201311. https:\/\/doi.org\/10.1016\/j.canrad.2020.06.007","journal-title":"Cancer Radiother"},{"key":"2291_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0961203309103150","volume":"18","author":"PL Carrillo-Alascio","year":"2009","unstructured":"Carrillo-Alascio PL, Sabio JM, N\u00fa\u00f1ez-Torres MI, L\u00f3pez E, Mu\u00f1oz-G\u00e1mez JA, Hidalgo-Tenorio C, J\u00e1imez L, Mart\u00edn J, Jim\u00e9nez-Alonso J. In-vitro radiosensitivity in patients with systemic lupus erythematosus. Lupus. 2009;18:645\u20139. https:\/\/doi.org\/10.1177\/0961203309103150","journal-title":"Lupus"},{"key":"2291_CR15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/s0360-3016(02)04415-2","volume":"55","author":"O Popanda","year":"2003","unstructured":"Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, Schmezer P, Thielmann HW, von Fournier D, Haase W, Sautter-Bihl ML, et al. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55:1216\u201325. https:\/\/doi.org\/10.1016\/s0360-3016(02)04415-2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2291_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.clon.2004.01.011","volume":"16","author":"T Leong","year":"2004","unstructured":"Leong T, Borg M, McKay M. Clinical and Cellular Radiosensitivity in inherited human syndromes. Clin Oncol (R Coll Radiol (G B)). 2004;16:206\u20139. https:\/\/doi.org\/10.1016\/j.clon.2004.01.011","journal-title":"Clin Oncol (R Coll Radiol (G B))"},{"key":"2291_CR17","doi-asserted-by":"publisher","unstructured":"Ott OJ, Stillkrieg W, Lambrecht U, Sauer T-O, Schweizer C, Lamrani A, Strnad V, Hack CC, Beckmann MW, Uder M, et al. External Beam Accelerated partial breast irradiation in early breast Cancer and the risk for Radiogenic Pneumonitis. Cancers. 2022;14. https:\/\/doi.org\/10.3390\/cancers14143520","DOI":"10.3390\/cancers14143520"},{"key":"2291_CR18","doi-asserted-by":"publisher","unstructured":"Vinnikov V, Hande MP, Wilkins R, Wojcik A, Zubizarreta E, Belyakov O. Prediction of the Acute or Late Radiation Toxicity Effects in Radiotherapy Patients using Ex vivo Induced Biodosimetric markers: a review. J Pers Med. 2020;10. https:\/\/doi.org\/10.3390\/jpm10040285","DOI":"10.3390\/jpm10040285"},{"key":"2291_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0167-8140(01)00457-1","volume":"61","author":"H Jung","year":"2001","unstructured":"Jung H, Beck-Bornholdt HP, Svoboda V, Alberti W, Herrmann T. Quantification of late complications after radiation therapy. Radiother Oncol. 2001;61:233\u201346.","journal-title":"Radiother Oncol"},{"key":"2291_CR20","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/s0360-3016(03)00188-3","volume":"56","author":"E Dikomey","year":"2003","unstructured":"Dikomey E, Borgmann K, Peacock J, Jung H. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys. 2003;56:1194\u2013200. https:\/\/doi.org\/10.1016\/s0360-3016(03)00188-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2291_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.radonc.2003.10.001","volume":"69","author":"U Hoeller","year":"2003","unstructured":"Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, Alberti W, Dikomey E. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol. 2003;69:137\u201344. https:\/\/doi.org\/10.1016\/j.radonc.2003.10.001","journal-title":"Radiother Oncol"},{"key":"2291_CR22","doi-asserted-by":"publisher","first-page":"20150172","DOI":"10.1259\/bjr.20150172","volume":"88","author":"JE Scaife","year":"2015","unstructured":"Scaife JE, Barnett GC, Noble DJ, Jena R, Thomas SJ, West CM, Burnet NG. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015;88:20150172. https:\/\/doi.org\/10.1259\/bjr.20150172","journal-title":"Br J Radiol"},{"key":"2291_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00066-017-1096-y","volume":"193","author":"C Nieder","year":"2017","unstructured":"Nieder C. Einfluss von Dosis und Fraktionierung auf die kurativ intendierte Strahlentherapie nicht-kleinzelliger Bronchialkarzinome. Strahlenther Onkol. 2017;193:240\u20132. https:\/\/doi.org\/10.1007\/s00066-017-1096-y","journal-title":"Strahlenther Onkol"},{"key":"2291_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0167-8140(99)00158-9","volume":"55","author":"JBP Barber","year":"2000","unstructured":"Barber JBP, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol. 2000;55:179\u201386. https:\/\/doi.org\/10.1016\/S0167-8140(99)00158-9","journal-title":"Radiother Oncol"},{"key":"2291_CR25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/BF03038185","volume":"173","author":"C Streffer","year":"1997","unstructured":"Streffer C. Genetische Pr\u00e4disposition und Strahlenempfindlichkeit bei normalen Geweben. Strahlenther Onkol. 1997;173:462\u20138. https:\/\/doi.org\/10.1007\/BF03038185","journal-title":"Strahlenther Onkol"},{"key":"2291_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00066-004-1200-y","volume":"180","author":"U Keller","year":"2004","unstructured":"Keller U, Kuechler A, Liehr T, M\u00fcller E, Grabenbauer G, Sauer R, Distel L. Impact of various parameters inDetecting chromosomal aberrations by FISH to DescribeRadiosensitivity. Strahlenther Onkol. 2004;180:289\u201396. https:\/\/doi.org\/10.1007\/s00066-004-1200-y","journal-title":"Strahlenther Onkol"},{"key":"2291_CR27","first-page":"67","volume":"17","author":"SH Ghasemi","year":"2015","unstructured":"Ghasemi SH, Monfared A, Borzouei-Sileh S, Zabihi E, Amiri M, Abedian Z. Predicting factors of Radiosensitivity in Individual Radiotherapy. J Babol Univ Med Sci. 2015;17:67\u201373.","journal-title":"J Babol Univ Med Sci"},{"key":"2291_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","volume":"5","author":"D De Ruysscher","year":"2019","unstructured":"De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F. Radiotherapy toxicity. Nat Rev Dis Primers. 2019;5:13. https:\/\/doi.org\/10.1038\/s41572-019-0064-5","journal-title":"Nat Rev Dis Primers"},{"key":"2291_CR29","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.3390\/ijms22137158","volume":"22","author":"L El-Nachef","year":"2021","unstructured":"El-Nachef L, Al-Choboq J, Restier-Verlet J, Granzotto A, Berthel E, Sonzogni L, Ferlazzo ML, Bouchet A, Leblond P, Combemale P, et al. Human radiosensitivity and radiosusceptibility: what are the differences? Int J Mol Sci. 2021;22:7158. https:\/\/doi.org\/10.3390\/ijms22137158","journal-title":"Int J Mol Sci"},{"key":"2291_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/00000441-199302000-00011","volume":"305","author":"B Mukerji","year":"1993","unstructured":"Mukerji B, Hardin JG. Undifferentiated, overlapping, and mixed connective tissue diseases. Am J Med Sci. 1993;305:114\u20139. https:\/\/doi.org\/10.1097\/00000441-199302000-00011","journal-title":"Am J Med Sci"},{"key":"2291_CR31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.ijrobp.2021.08.006","volume":"111","author":"PM Shaikh","year":"2021","unstructured":"Shaikh PM, Singh SA, Alite F, Vargo JA, Emami B, Wu M-J, Jacobson G, Bakalov V, Small W, Dahshan B, et al. Radiation toxicity in patients with collagen vascular disease: a Meta-analysis of case-control studies. Int J Radiation Oncology*Biology*Physics. 2021;111:1214\u201326. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.08.006","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"2291_CR32","doi-asserted-by":"crossref","unstructured":"Phan C, Mindrum M, Silverman C, Paris K, Spanos W. Matched-Control Retrospective Study of the Acute and Late Complications in Patients with Collagen Vascular Diseases Treated with Radiation Therapy. The Cancer Journal 2003, 9.","DOI":"10.1097\/00130404-200311000-00005"},{"key":"2291_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF03038536","volume":"174","author":"S Neubauer","year":"1998","unstructured":"Neubauer S. Akute und chronische strahlenfolgen bei patienten mit kollagenosen. Strahlenther Onkol. 1998;174:225\u20136. https:\/\/doi.org\/10.1007\/BF03038536","journal-title":"Strahlenther Onkol"},{"key":"2291_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/09553008514550931","volume":"47","author":"G Harris","year":"1985","unstructured":"Harris G, Cramp WA, Edwards JC, George AM, Sabovljev SA, Hart L, Hughes GRV, Denman AM, Yatvin MB. Radiosensitivity of Peripheral Blood Lymphocytes in Autoimmune Disease. Int J Radiation Biology Relat Stud Phys Chem Med. 1985;47:689\u201399. https:\/\/doi.org\/10.1080\/09553008514550931","journal-title":"Int J Radiation Biology Relat Stud Phys Chem Med"},{"key":"2291_CR35","doi-asserted-by":"publisher","unstructured":"Diao K, Chen YH, Catalano PS, Lee S, Milani N, Killoran JH, Baldini EH, Chen AB, Kozono DE, Mak RH. Radiation Toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern Radiotherapy. Int J Radiat Oncol Biol Phys. 2017;99. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.275","DOI":"10.1016\/j.ijrobp.2017.06.275"},{"key":"2291_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<612::AID-CNCR26>3.0.CO;2-5","volume":"79","author":"NA Mayr","year":"1997","unstructured":"Mayr NA, Riggs CE Jr, Saag KG, Wen BC, Pennington EC, Hussey DH. Mixed connective tissue disease and radiation toxicity. Cancer. 1997;79:612\u20138. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19970201)79:3%3C612::AID-CNCR26%3E3.0.CO;2-5","journal-title":"Cancer"},{"key":"2291_CR37","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319. https:\/\/doi.org\/10.1056\/NEJMra1004965","journal-title":"N Engl J Med"},{"key":"2291_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett G, McInnes IB, Neurath MF. Reframing Immune-Mediated inflammatory Diseases through signature cytokine hubs. N Engl J Med. 2021;385:628\u201339. https:\/\/doi.org\/10.1056\/NEJMra1909094","journal-title":"N Engl J Med"},{"key":"2291_CR39","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev. 2021;20:102776. https:\/\/doi.org\/10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun Rev"},{"key":"2291_CR40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/s0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094\u2013108. https:\/\/doi.org\/10.1016\/s0140-6736(10)60826-4","journal-title":"Lancet"},{"key":"2291_CR41","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360\u201372. https:\/\/doi.org\/10.1001\/jama.2018.13103","journal-title":"JAMA"},{"key":"2291_CR42","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10067-019-04602-5","volume":"38","author":"O Gadeholt","year":"2019","unstructured":"Gadeholt O, Hausotter K, Eberle H, Klink T, Pfeil A. Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis. Clin Rheumatol. 2019;38:2403\u201310. https:\/\/doi.org\/10.1007\/s10067-019-04602-5","journal-title":"Clin Rheumatol"},{"key":"2291_CR43","doi-asserted-by":"publisher","first-page":"e0195550","DOI":"10.1371\/journal.pone.0195550","volume":"13","author":"S Choi","year":"2018","unstructured":"Choi S, Lee KH. Clinical management of seronegative and seropositive rheumatoid arthritis: a comparative study. PLoS ONE. 2018;13:e0195550. https:\/\/doi.org\/10.1371\/journal.pone.0195550","journal-title":"PLoS ONE"},{"key":"2291_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10067-016-3494-4","volume":"36","author":"G Barouta","year":"2017","unstructured":"Barouta G, Katsiari CG, Alexiou I, Liaskos C, Varna A, Bogdanos DP, Germenis AE, Sakkas LI. Anti-MCV antibodies predict radiographic progression in greek patients with very early (< 3 months duration) rheumatoid arthritis. Clin Rheumatol. 2017;36:885\u201394. https:\/\/doi.org\/10.1007\/s10067-016-3494-4","journal-title":"Clin Rheumatol"},{"key":"2291_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.23188","volume":"58","author":"L Mathsson","year":"2008","unstructured":"Mathsson L, Mullazehi M, Wick MC, Sj\u00f6berg O, van Vollenhoven R, Klareskog L, R\u00f6nnelid J. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum. 2008;58:36\u201345. https:\/\/doi.org\/10.1002\/art.23188","journal-title":"Arthritis Rheum"},{"key":"2291_CR46","first-page":"884","volume":"31","author":"MM Ward","year":"2004","unstructured":"Ward MM. Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis. J Rheumatol. 2004;31:884\u201395.","journal-title":"J Rheumatol"},{"key":"2291_CR47","first-page":"40","volume":"34","author":"PL van Riel","year":"2016","unstructured":"van Riel PL, Renskers L. The Disease activity score (DAS) and the Disease Activity score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34:40\u2013s44.","journal-title":"Clin Exp Rheumatol"},{"key":"2291_CR48","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1002\/jcp.27860","volume":"234","author":"M Abbasi","year":"2019","unstructured":"Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019;234:10018\u201331. https:\/\/doi.org\/10.1002\/jcp.27860","journal-title":"J Cell Physiol"},{"key":"2291_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-022-01945-y","author":"T Jost","year":"2022","unstructured":"Jost T, Schuster B, Heinzerling L, Weissmann T, Fietkau R, Distel LV, Hecht M. Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients. Strahlenther Onkol. 2022. https:\/\/doi.org\/10.1007\/s00066-022-01945-y","journal-title":"Strahlenther Onkol"},{"key":"2291_CR50","doi-asserted-by":"publisher","unstructured":"Schuster B, Hecht M, Schmidt M, Haderlein M, Jost T, B\u00fcttner-Herold M, Weber K, Denz A, Gr\u00fctzmann R, Hartmann A, et al. Influence of gender on Radiosensitivity during Radiochemotherapy of Advanced rectal Cancer. Cancers (Basel). 2021;14. https:\/\/doi.org\/10.3390\/cancers14010148","DOI":"10.3390\/cancers14010148"},{"key":"2291_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-3-540-70581-9_21","volume-title":"Fluorescence in situ hybridization (FISH) \u2014 application guide","author":"L Distel","year":"2009","unstructured":"Distel L, Keller U, Neubauer S. Three-color FISH for the detection of individual radiosensitivity. In: Liehr T, editor. Fluorescence in situ hybridization (FISH) \u2014 application guide. Berlin Heidelberg: Berlin, Heidelberg,: Springer; 2009. pp. 231\u201341."},{"key":"2291_CR52","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0027-5107(94)90308-5","volume":"307","author":"JRK Savage","year":"1994","unstructured":"Savage JRK, Simpson P. On the scoring of FISH-\u201cpainted\u201d chromosome-type exchange aberrations. Mutat Research\/Fundamental Mol Mech Mutagen. 1994;307:345\u201353. https:\/\/doi.org\/10.1016\/0027-5107(94)90308-5","journal-title":"Mutat Research\/Fundamental Mol Mech Mutagen"},{"key":"2291_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0167-8140(97)01932-4","volume":"43","author":"S Neubauer","year":"1997","unstructured":"Neubauer S, Dunst J, Gebhart E. The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. Radiother Oncol. 1997;43:189\u201395. https:\/\/doi.org\/10.1016\/S0167-8140(97)01932-4","journal-title":"Radiother Oncol"},{"key":"2291_CR54","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.radonc.2015.07.002","volume":"116","author":"K Ulrike","year":"2015","unstructured":"Ulrike K, Markus H, Thomas H, Ellen H, Barbara S, Rainer F, Distel LV. NNRTI-based antiretroviral therapy may increase risk of radiation induced side effects in HIV-1-infected patients. Radiother Oncol. 2015;116:323\u201330. https:\/\/doi.org\/10.1016\/j.radonc.2015.07.002","journal-title":"Radiother Oncol"},{"key":"2291_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2307\/3579194","volume":"145","author":"E Gebhart","year":"1996","unstructured":"Gebhart E, Neubauer S, Schmitt G, Birkenhake S, Dunst J. Use of a three-color chromosome in situ suppression technique for the detection of past Radiation exposure. Radiat Res. 1996;145:47\u201352. https:\/\/doi.org\/10.2307\/3579194","journal-title":"Radiat Res"},{"key":"2291_CR56","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1667\/0033-7587(2002)157[0312:roatan]2.0.co;2","volume":"157","author":"S Neubauer","year":"2002","unstructured":"Neubauer S, Arutyunyan R, Stumm M, D\u00f6rk T, Bendix R, Bremer M, Varon R, Sauer R, Gebhart E. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiat Res. 2002;157:312\u201321. https:\/\/doi.org\/10.1667\/0033-7587(2002)157[0312:roatan]2.0.co;2","journal-title":"Radiat Res"},{"key":"2291_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cancergencyto.2004.05.018","volume":"157","author":"U Keller","year":"2005","unstructured":"Keller U, Grabenbauer G, Kuechler A, Sprung CN, M\u00fcller E, Sauer R, Distel L. Cytogenetic instability in young patients with multiple primary cancers. Cancer Genet Cytogenet. 2005;157:25\u201332. https:\/\/doi.org\/10.1016\/j.cancergencyto.2004.05.018","journal-title":"Cancer Genet Cytogenet"},{"key":"2291_CR58","doi-asserted-by":"publisher","unstructured":"Mayo T, Haderlein M, Schuster B, Wiesm\u00fcller A, Hummel C, Bachl M, Schmidt M, Fietkau R, Distel L. Is in vivo and ex vivo irradiation equally reliable for individual radiosensitivity testing by three colour fluorescence in situ hybridization? Radiat Oncol. 2019;15(2). https:\/\/doi.org\/10.1186\/s13014-019-1444-4","DOI":"10.1186\/s13014-019-1444-4"},{"key":"2291_CR59","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12883-020-01966-z","volume":"20","author":"J Stritzelberger","year":"2020","unstructured":"Stritzelberger J, Lainer J, Gollwitzer S, Graf W, Jost T, Lang JD, Mueller TM, Schwab S, Fietkau R, Hamer HM, et al. Ex vivo radiosensitivity is increased in non-cancer patients taking valproate. BMC Neurol. 2020;20:390. https:\/\/doi.org\/10.1186\/s12883-020-01966-z","journal-title":"BMC Neurol"},{"key":"2291_CR60","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.radonc.2005.12.013","volume":"78","author":"T H\u00f6lscher","year":"2006","unstructured":"H\u00f6lscher T, Bentzen S, Baumann M. Influence of connective tissue diseases on the expression of radiation side effects: a systematic review. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2006;78:123\u201330. https:\/\/doi.org\/10.1016\/j.radonc.2005.12.013","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"2291_CR61","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10549-017-4438-7","volume":"166","author":"Y Dong","year":"2017","unstructured":"Dong Y, Li T, Churilla TM, Shaikh T, Sigurdson ER, Bleicher RJ, Weiss SE, Hayes SB, Anderson PR. Impact of rheumatoid arthritis on radiation-related toxicity and cosmesis in breast cancer patients: a contemporary matched-pair analysis. Breast Cancer Res Treat. 2017;166:787\u201391. https:\/\/doi.org\/10.1007\/s10549-017-4438-7","journal-title":"Breast Cancer Res Treat"},{"key":"2291_CR62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canrad.2016.09.020","volume":"21","author":"T Felefly","year":"2017","unstructured":"Felefly T, Mazeron R, Huertas A, Canova CH, Maroun P, Kordahi M, Morice P, Deutsch \u00c9, Haie-M\u00e9der C, Chargari C. Pelvic radiotherapy in the setting of rheumatoid arthritis: Refining the paradigm. Cancer\/Radioth\u00e9rapie. 2017;21:109\u201313. https:\/\/doi.org\/10.1016\/j.canrad.2016.09.020","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"2291_CR63","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/0360-3016(89)90074-6","volume":"17","author":"R Fleck","year":"1989","unstructured":"Fleck R, McNeese MD, Ellerbroek NA, Hunter TA, Holmes FA. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys. 1989;17:829\u201333. https:\/\/doi.org\/10.1016\/0360-3016(89)90074-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2291_CR64","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijrobp.2006.09.003","volume":"67","author":"DG Gold","year":"2007","unstructured":"Gold DG, Miller RC, Petersen IA, Osborn TG. Radiotherapy for malignancy in patients with scleroderma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2007;67:559\u201367. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.09.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2291_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1017\/S146039690700502X","volume":"6","author":"YM Kirova","year":"2007","unstructured":"Kirova YM, Bollet MA, Dys I, Campana F, Laki F, Dendale R, Salmon R, Fourquet A. Scleroderma and radiotherapy as part of the treatment of breast carcinoma: six cases and a short critical review of the literature. I Radiother Pract. 2007;6:47\u201351. https:\/\/doi.org\/10.1017\/S146039690700502X","journal-title":"I Radiother Pract"},{"key":"2291_CR66","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1440-1673.1987.tb01840.x","volume":"31","author":"DT Ransom","year":"1987","unstructured":"Ransom DT, Cameron FG. Scleroderma\u2013a possible contra-indication to lumpectomy and radiotherapy in breast carcinoma. Australas Radiol. 1987;31:317\u20138. https:\/\/doi.org\/10.1111\/j.1440-1673.1987.tb01840.x","journal-title":"Australas Radiol"},{"key":"2291_CR67","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/acr.23505","volume":"70","author":"DJ Shah","year":"2018","unstructured":"Shah DJ, Hirpara R, Poelman CL, Woods A, Hummers LK, Wigley FM, Wright JL, Parekh A, Steen VD, Domsic RT, et al. Impact of Radiation Therapy on Scleroderma and Cancer Outcomes in Scleroderma patients with breast Cancer. Arthritis Care Res. 2018;70:1517\u201324. https:\/\/doi.org\/10.1002\/acr.23505","journal-title":"Arthritis Care Res"},{"key":"2291_CR68","doi-asserted-by":"publisher","first-page":"8675","DOI":"10.2147\/cmar.s264795","volume":"12","author":"J Ma","year":"2020","unstructured":"Ma J, Wang W, Shen J, Hou X, Lian X, Yan J, Sun S, Miao Z, Meng Q, Hu K, et al. Radiotherapy for Cervical Cancer in patients with systemic Lupus Erythematosus. Cancer Manag Res. 2020;12:8675\u201383. https:\/\/doi.org\/10.2147\/cmar.s264795","journal-title":"Cancer Manag Res"},{"key":"2291_CR69","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2007.10.014","volume":"71","author":"ME Pinn","year":"2008","unstructured":"Pinn ME, Gold DG, Petersen IA, Osborn TG, Brown PD, Miller RC. Systemic Lupus Erythematosus, Radiotherapy, and the risk of Acute and Chronic Toxicity: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys. 2008;71:498\u2013506. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.10.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2291_CR70","doi-asserted-by":"publisher","unstructured":"Patel AB, Hallemeier CL, Petersen IA, Jensen AW, Osborn TG, Miller RC. Acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus: a retrospective case-control study. Radiat Oncol. 2012;7. https:\/\/doi.org\/10.1186\/1748-717X-7-22","DOI":"10.1186\/1748-717X-7-22"},{"key":"2291_CR71","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1346-8138.2005.tb00752.x","volume":"32","author":"A Ishida-Yamamoto","year":"2005","unstructured":"Ishida-Yamamoto A, Kanno K, Sato E, Takahashi H, Iizuka H. Discoid lupus erythematosus exacerbated by radiation therapy. J Dermatol; England. 2005;32:225\u20136.","journal-title":"J Dermatol; England"},{"key":"2291_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/art.20912","volume":"53","author":"V Benk","year":"2005","unstructured":"Benk V, Al-Herz A, Gladman D, Urowitz M, Fortin PR. Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer. Arthritis Care Res. 2005;53:67\u201372. https:\/\/doi.org\/10.1002\/art.20912","journal-title":"Arthritis Care Res"},{"key":"2291_CR73","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0360-3016(89)90344-1","volume":"16","author":"P Teo","year":"1989","unstructured":"Teo P, Tai TH, Choy D. Nasopharyngeal carcinoma with dermatomyositis. Int J Radiation Oncology*Biology*Physics. 1989;16:471\u20134. https:\/\/doi.org\/10.1016\/0360-3016(89)90344-1","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"2291_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2004.08.019","volume":"74","author":"R Ben-Yosef","year":"2005","unstructured":"Ben-Yosef R, Soyfer V, Vexler A. Radiation therapy in cancer patients with psoriasis. The fractionated daily dose and the Koebner phenomenon. Radiother Oncol. 2005;74:21\u20133. https:\/\/doi.org\/10.1016\/j.radonc.2004.08.019","journal-title":"Radiother Oncol"},{"key":"2291_CR75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.toxlet.2003.12.044","volume":"149","author":"A Vral","year":"2004","unstructured":"Vral A, Thierens H, Baeyens A, De Ridder L. Chromosomal aberrations and in vitro radiosensitivity: intra-individual versus inter-individual variability. Toxicol Lett. 2004;149:345\u201352. https:\/\/doi.org\/10.1016\/j.toxlet.2003.12.044","journal-title":"Toxicol Lett"},{"key":"2291_CR76","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/S1470-2045(15)00417-9","volume":"17","author":"N Giaj-Levra","year":"2016","unstructured":"Giaj-Levra N, Sciascia S, Fiorentino A, Fersino S, Mazzola R, Ricchetti F, Roccatello D, Alongi F. Radiotherapy in patients with connective tissue diseases. Lancet Oncol. 2016;17:e109\u201317. https:\/\/doi.org\/10.1016\/S1470-2045(15)00417-9","journal-title":"Lancet Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02291-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02291-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02291-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T13:04:57Z","timestamp":1686143097000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02291-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02291-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"17 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients and healthy individuals gave their written informed consent to the scientific processing of their material and data. The Ethics Review Committee of the Universit\u00e4tsklinikum Erlangen approved the study including the use of individual patient data. Ethics committee approval 21_19 B.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}